BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21286781)

  • 1. A cytotoxic ribonuclease reduces the expression level of P-glycoprotein in multidrug-resistant cell lines.
    Castro J; Ribó M; Puig T; Colomer R; Vilanova M; Benito A
    Invest New Drugs; 2012 Jun; 30(3):880-8. PubMed ID: 21286781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A human ribonuclease induces apoptosis associated with p21WAF1/CIP1 induction and JNK inactivation.
    Castro J; Ribó M; Navarro S; Nogués MV; Vilanova M; Benito A
    BMC Cancer; 2011 Jan; 11():9. PubMed ID: 21223552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of new cytotoxic human ribonuclease variants directed to the nucleus.
    Vert A; Castro J; Ruiz-Martínez S; Tubert P; Escribano D; Ribó M; Vilanova M; Benito A
    Mol Pharm; 2012 Oct; 9(10):2894-902. PubMed ID: 22957849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of multidrug resistant in cancer cells by EGCG, tannic acid and curcumin.
    Li H; Krstin S; Wink M
    Phytomedicine; 2018 Nov; 50():213-222. PubMed ID: 30466981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carnosine Potentiates Doxorubicin-Induced Cytotoxicity in Resistant NCI/ADR-RES Cells by Inhibiting P-Glycoprotein-In Silico and In Vitro Evidence.
    Morsy MA; Kandeel M; Ibrahim ARN; Abdel-Gaber SA; Jacob S; Venugopala KN; Shinu P; El-Daly M
    Molecules; 2022 Oct; 27(21):. PubMed ID: 36364209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A nuclear-directed human pancreatic ribonuclease (PE5) targets the metabolic phenotype of cancer cells.
    Vert A; Castro J; Ribó M; Benito A; Vilanova M
    Oncotarget; 2016 Apr; 7(14):18309-24. PubMed ID: 26918450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line.
    Li J; Xu LZ; He KL; Guo WJ; Zheng YH; Xia P; Chen Y
    Breast Cancer Res; 2001; 3(4):253-63. PubMed ID: 11434876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transport of new non-cross-resistant antitumor compounds of the benzoperimidine family in multidrug resistant cells.
    Tkaczyk-Gobis K; Tarasiuk J; Seksek O; Stefanska B; Borowski E; Garnier-Suillerot A
    Eur J Pharmacol; 2001 Feb; 413(2-3):131-41. PubMed ID: 11226386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 6-(7-Nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol, a specific glutathione S-transferase inhibitor, overcomes the multidrug resistance (MDR)-associated protein 1-mediated MDR in small cell lung cancer.
    Filomeni G; Turella P; Dupuis ML; Forini O; Ciriolo MR; Cianfriglia M; Pezzola S; Federici G; Caccuri AM
    Mol Cancer Ther; 2008 Feb; 7(2):371-9. PubMed ID: 18281520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulfocoumarins, specific carbonic anhydrase IX and XII inhibitors, interact with cancer multidrug resistant phenotype through pH regulation and reverse P-glycoprotein mediated resistance.
    Podolski-Renić A; Dinić J; Stanković T; Jovanović M; Ramović A; Pustenko A; Žalubovskis R; Pešić M
    Eur J Pharm Sci; 2019 Oct; 138():105012. PubMed ID: 31330259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purine analogs sensitize the multidrug resistant cell line (NCI-H460/R) to doxorubicin and stimulate the cell growth inhibitory effect of verapamil.
    Pesić M; Podolski A; Rakić L; Ruzdijić S
    Invest New Drugs; 2010 Aug; 28(4):482-92. PubMed ID: 19533022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifactorial involvement of multidrug resistance-associated [correction of resistance] protein, DNA topoisomerase II and glutathione/glutathione-S-transferase in nonP-glycoprotein-mediated multidrug resistance in human bladder cancer cells.
    Kim WJ; Kakehi Y; Yoshida O
    Int J Urol; 1997 Nov; 4(6):583-90. PubMed ID: 9477189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function.
    Teng YN; Sheu MJ; Hsieh YW; Wang RY; Chiang YC; Hung CC
    Phytomedicine; 2016 Mar; 23(3):316-23. PubMed ID: 26969385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway.
    Chen T; Wang C; Liu Q; Meng Q; Sun H; Huo X; Sun P; Peng J; Liu Z; Yang X; Liu K
    Cancer Biol Ther; 2015; 16(1):106-14. PubMed ID: 25482933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indoloquinoxaline compounds that selectively antagonize P-glycoprotein.
    Smith CD; Myers CB; Zilfou JT; Smith SN; Lawrence DS
    Oncol Res; 2000; 12(5):219-29. PubMed ID: 11417747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
    David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
    Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of vincristine cytotoxicity in drug-resistant cells by simultaneous treatment with onconase, an antitumor ribonuclease.
    Rybak SM; Pearson JW; Fogler WE; Volker K; Spence SE; Newton DL; Mikulski SM; Ardelt W; Riggs CW; Kung HF; Longo DL
    J Natl Cancer Inst; 1996 Jun; 88(11):747-53. PubMed ID: 8637029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucosylceramide synthase upregulates MDR1 expression in the regulation of cancer drug resistance through cSrc and beta-catenin signaling.
    Liu YY; Gupta V; Patwardhan GA; Bhinge K; Zhao Y; Bao J; Mehendale H; Cabot MC; Li YT; Jazwinski SM
    Mol Cancer; 2010 Jun; 9():145. PubMed ID: 20540746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-(3,4,5-trimethoxybenzoyl)-4-methyl-2-(p-tolyl) imidazol (BZML) targets tubulin and DNA to induce anticancer activity and overcome multidrug resistance in colorectal cancer cells.
    Bai Z; Liu X; Guan Q; Ding N; Wei Q; Tong B; Zhao M; Zhang W; Ma L
    Chem Biol Interact; 2020 Jan; 315():108886. PubMed ID: 31682804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of endogenous multidrug resistance 1 and P-glycoprotein expression on anticancer drug resistance in colon cancer cell lines.
    Washio I; Nakanishi T; Ishiguro N; Bister B; Tamai I
    Biopharm Drug Dispos; 2019 Jan; 40(1):32-43. PubMed ID: 30556139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.